LINDSAY PRINCER: Open Payments
NPI 1336848837 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,141 in 40 payments from 7 companies in 2025. Trend: 2023 $109 · 2024 $1,307 · 2025 $3,141
Food & beverage: $1,900Travel & lodging: $1,240
| Company | Payments | Amount |
|---|---|---|
| AERIN MEDICAL INC. | 13 | $1,720 |
| Regeneron Healthcare Solutions, Inc. | 6 | $483 |
| REVANCE THERAPEUTICS, INC. | 1 | $316 |
| GENZYME CORPORATION | 11 | $266 |
| ABBVIE INC. | 3 | $145 |
| Optinose US, Inc. | 2 | $142 |
| GlaxoSmithKline, LLC. | 4 | $68 |
Products named: VIVAER STYLUS, DUPIXENT, DAXXIFY, Xhance, BOTOX, NUCALA, LUMIGAN.
Industry payments across NY — which companies pay providers there.
